Company Directory / Pharmaceuticals
DelistedFor profitPharmaceuticalsAlderley Park, Macclesfield, United Kingdom
Redx Pharma
Redx Pharma is a drug discovery and development company.
- Founded
- 2010 16 years ago
- Staff
- 51-100 71 on LinkedIn
- Followers
- 12k on LinkedIn
- Funding
- $103M as listed, USD
Redx Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic diseases Our team of scientists are based at our labs at Alderley Park, Cheshire, the UK’s largest single site life science campus. The team is made up of world class medicinal chemistry, biology and clinical capability with deep-rooted biotech and large pharma experience. Redx's lead asset, the selective ROCK2 inhibitor,… Read all
Redx Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic diseases Our team of scientists are based at our labs at Alderley Park, Cheshire, the UK’s largest single site life science campus. The team is made up of world class medicinal chemistry, biology and clinical capability with deep-rooted biotech and large pharma experience. Redx's lead asset, the selective ROCK2 inhibitor, zelasudil (RXC007), is in development for idiopathic pulmonary fibrosis and commenced a Phase 2 clinical trial in Q4 2022. Redx’s second ROCK inhibitor candidate, RXC008, a GI-targeted pan-ROCK inhibitor for the treatment of fibrostenotic Crohn’s disease, commenced a Phase 1 clinical trial in Q1 2024. The Company's lead oncology product candidate, the Porcupine inhibitor, zamaporvint (RXC004), commenced a Phase 2 programme in November 2021. The Company has a strong track record of discovering new drug candidates through its core strengths in medicinal chemistry and translational science, enabling the Company to discover and develop differentiated therapeutics against biologically or clinically validated targets. Read more about our company at https://www.redxpharma.com/about-us/ If you're interested in joining us, please visit https://www.redxpharma.com to see what job vacancies we currently have.
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed. 71 people list it on LinkedIn.
Age
16 years old.
Reach
Website ranked #7,461,736 in the world for traffic, about 762 visits a month. 11,973 followers on LinkedIn.
What it does
BiotechnologyHealth CareMedicalPharmaceuticalOncologyFibrosisPharmaceuticalsDrug Discovery and DevelopmentBiotech
What it is known for
oncologyfibrosispharmaceuticalsdrug discovery developmentbiotechpharmaceutical manufacturingfibrotic diseasescollaborationsfibrosis reversalrock inhibitorsmolecular targetswnt pathway inhibitorstargeted therapygi-restricted pan-rock inhibitortherapeutic pipelinecollagen synthesis inhibitors
What its website runs on
Google Search ConsoleMicrosoft Email ProvidersMicrosoft Exchange OnlineOutlookMicrosoft ExchangeAtlassianMicrosoft 365Microsoft 365 Apps & ServicesTeamViewerDigitalOceanHotjarGoogle Maps PlatformGoogle Hosted LibrariesRSSTablePressNginxGoogle AnalyticsAdobe Illustrator
Funding, as listed
$103M raised in total
- Rounds8
- LatestPost ipo equity, May 2022
- Latest amountUSD 43,620,773
- Investors9, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Redx Pharma, field by field. Contact details are held but never shown.
The company
- Name
- Redx Pharma
- Type
- For profit
- Status
- Delisted
- Founded
- 2010
- Founders
- Derek Lindsay
- Industry
- Pharmaceuticals
- Categories
- Biotechnology, Health Care, Medical, Pharmaceutical
- Specialities
- Oncology, Fibrosis, Pharmaceuticals, Drug Discovery and Development, Biotech
Where
- City
- Alderley Park
- Region
- Macclesfield
- Country
- United Kingdom
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- People on LinkedIn
- 71
- LinkedIn followers
- 11,973
- Web traffic rank
- #7,461,736
- Monthly web visits
- 762
- Annual revenue
- $14M
Funding, as listed
- Total
- $103,114,263 USD
- Rounds
- 8
- Latest round
- Post ipo equity
- Latest round date
- May 2022
- Latest amount
- 43,620,773 USD
- Investors
- 9
- Lead investors
- 4
- Listing status
- delisted
Corporate family
- Part of
- Jounce Therapeutics, Inc.
- Parent website
- jouncetx.com
Classification
- NAICS
- 541714, 325412
- SIC
- 8731
- Keywords
- 16 listed, shown above
- Technologies
- 18 detected, shown above
About this record
- Sources
- Crunchbase, LinkedIn, Apollo
- Last imported
- Sept 2026
Growth, as the source summarises it
Redx Pharma may be growing as evidenced by the impressive return of 272% to investors over the last five years, which suggests a strong performance and potential growth in the company's valuation. Additionally, the consideration of a New York listing indicates a strategic move to potentially increase capital and expand its investor base. Despite a later denial of immediate plans for a US listing, the initial interest in such a move could reflect an underlying growth trajectory and ambition for expansion.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Pharmaceuticals in United Kingdom.
Ferring Controlled TherapeuticsEast Kilbride · 5001-10000 people · 1k followers
Oxford BioMedicaOxford · 501-1000 people · 47k followers
Archimedes PharmaReading · 51-100 people · 4k followersCCellZome51-100 people · 2k followers
EUSA PharmaHemel Hempstead · 51-100 people · 14k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.